Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Terreno Realty Corporation A Lucrative Investment Opportunity in Industrial Real Estate

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Real-estate-invest
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Imagine if you had decided to invest $10,000 in Terreno Realty Corporation (NYSE: TRNO) back in March 2019. At that time, you would have been able to purchase 241.84 shares of the company at a price of $41.35 per share. Fast forward to March 13, 2024, and you would have seen an appreciation of 11.49% in the value of your investment.

Terreno Realty Corp. is a real estate investment trust specializing in industrial properties. They currently own and operate 259 properties, totaling 16 million square feet, in key U.S. coastal markets such as Miami, Northern New Jersey/New York City, Washington D.C., Seattle, Los Angeles, and San Francisco. With a customer base of 580 as of December 31, 2023, Terreno Realty focuses on acquiring properties in strategic locations near major population centers and transportation hubs.

As of March 13, 2024, Terreno Realty Corporation boasts a market capitalization of $5.63 billion, with a 52-week trading range of $50.42-$65.64. The company’s success lies in its commitment to acquiring functional and flexible properties in prime locations, making it an attractive investment option for those looking to capitalize on the industrial real estate sector.

TRNO Stock Shows Promising Performance Trading Near 52-Week High on March 13, 2024

On March 13, 2024, TRNO stock showed promising performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicated positive momentum for the stock.

The price of TRNO shares increased by $0.62 since the market last closed, representing a 0.95% rise. The stock opened at $64.48, which was $0.04 lower than its previous close. Despite the slight dip in the opening price, the stock quickly gained momentum and continued to rise throughout the trading day.

Investors may have been drawn to TRNO stock on March 13 due to its strong performance indicators. Trading near the top of its 52-week range suggests that the stock has been performing well compared to its historical prices. Additionally, trading above its 200-day simple moving average indicates a bullish trend for the stock.

TRNO Stock Performance Analysis: Revenue Up, Net Income Down

On March 13, 2024, TRNO stock had a mixed performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $323.59 million, showing an increase of 17.15% compared to the previous year. In the fourth quarter, total revenue was $86.48 million, which represented a 4.3% increase from the previous quarter.

However, the net income for TRNO was $150.75 million for the past year, but it decreased by 23.54% compared to the previous year. In the fourth quarter, the net income was $57.28 million, holding flat compared to the previous quarter.

Earnings per share (EPS) for TRNO were $1.81 for the past year, showing a decrease of 30.68% compared to the previous year. In the fourth quarter, EPS was $0.65, holding flat compared to the previous quarter.

Overall, TRNO stock showed a mixed performance on March 13, 2024. Investors may want to closely monitor the company’s financial performance and future outlook to make informed decisions regarding TRNO stock.

Tags: TRNO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
costco drug test policy

House of Representatives Passes Bill Requiring Sale of TikTok or Face Ban

Finance_Cash

Morgan Stanley Analyst Upgrades CrowdStrike Holdings with Higher Price Target

CTVA stock news

Anticipating Acacia Researchs Earnings Report Analyst Projections and Market Trends

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com